Dataset Information

IFN-?3 inhibits HIV infection of macrophages through the JAK-STAT pathway.

ABSTRACT: Interferon lambda 3 (IFN-?3) is a newly identified cytokine with antiviral activity, and its single nucleotide polymorphisms are strongly associated with the treatment effectiveness and development of chronic hepatitis C virus infection. We thus examined the potential of IFN-?3 to inhibit HIV replication and the possible mechanisms of the anti-HIV action by IFN-?3 in human macrophages.Under different conditions (before, during, and after HIV infection), IFN-?3 significantly inhibited viral replication in macrophages, which was associated with the induction of multiple antiviral cellular factors (ISG56, MxA, OAS-1, A3G/F and tetherin) and IFN regulatory factors (IRF-1, 3, 5, 7 and 9). This anti-HIV action of IFN-?3 could be compromised by the JAK-STAT inhibitor. In addition, IFN-?3 treatment of macrophages induced the expression of toll-like receptor 3 (TLR3) and two key adaptors (MyD88 and TRIF) in type I IFN pathway activation. However, HIV infection compromised IFN-?3-mediated induction of the key elements in JAK-STAT signaling pathway.These data indicate that IFN-?3 exerts its anti-HIV function by activating JAK-STAT pathway-mediated innate immunity in macrophages. Future in vivo studies are necessary in order to explore the potential for developing IFN-?3-based therapy for HIV disease.

SUBMITTER: Liu MQ

PROVIDER: S-EPMC3338759 | biostudies-other | 2012

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway.

Liu Man-Qing MQ Zhou Dun-Jin DJ Wang Xu X Zhou Wang W Ye Li L Li Jie-Liang JL Wang Yi-Zhong YZ Ho Wen-Zhe WZ

PloS one 20120427 4

<h4>Background</h4>Interferon lambda 3 (IFN-λ3) is a newly identified cytokine with antiviral activity, and its single nucleotide polymorphisms are strongly associated with the treatment effectiveness and development of chronic hepatitis C virus infection. We thus examined the potential of IFN-λ3 to inhibit HIV replication and the possible mechanisms of the anti-HIV action by IFN-λ3 in human macrophages.<h4>Principal findings</h4>Under different conditions (before, during, and after HIV infectio ...[more]

PMID: 22558263

Similar Datasets

Project description:Anti-retroviral therapy successfully suppresses HIV-1 infection, but fails to provide a cure. During infection Type 1 IFNs normally play an essential role in viral clearance, but in vivo IFN-? only has a modest impact on HIV-1 infection, suggesting its possible targeting by HIV. Here, we report that the HIV protein, Vif, inhibits effective IFN-? signalling via degradation of essential JAK/STAT pathway components. We found that STAT1 and STAT3 are specifically reduced in HEK293T cells expressing Vif and that full length, infectious HIV-1 IIIB strain promotes their degradation in a Vif-dependent manner. HIV-1 IIIB infection of myeloid ThP-1 cells also reduced the IFN-?-mediated induction of the anti-viral gene, ISG15, but not MxA, revealing a functional consequence of this HIV-1-mediated immune evasion strategy. Interestingly, while total STAT levels were not reduced upon in vitro IIIB infection of primary human PBMCs, IFN-?-mediated phosphorylation of STAT1 and STAT3 and ISG induction were starkly reduced, with removal of Vif (IIIB?Vif), partially restoring pSTATs, ISG15 and MxB induction. Similarly, pSTAT1 and pSTAT3 expression and IFN-?-induced ISG15 were reduced in PBMCs from HIV-infected patients, compared to healthy controls. Furthermore, IFN-? pre-treatment of a CEM T lymphoblast cells significantly inhibited HIV infection/replication (measured by cellular p24), only in the absence of Vif (IIIB?Vif), but was unable to suppress full length IIIB infection. When analysing the mechanism by which Vif might target the JAK/STAT pathway, we found Vif interacts with both STAT1 and STAT3, (but not STAT2), and its expression promotes ubiquitination and MG132-sensitive, proteosomal degradation of both proteins. Vif's Elongin-Cullin-SOCS-box binding motif enables the formation of an active E3 ligase complex, which we found to be required for Vif's degradation of STAT1 and STAT3. In fact, the E3 ligase scaffold proteins, Cul5 and Rbx2, were also found to be essential for Vif-mediated proteasomal degradation of STAT1 and STAT3. These results reveal a target for HIV-1-Vif and demonstrate how HIV-1 impairs the anti-viral activity of Type 1 IFNs, possibly explaining why both endogenous and therapeutic IFN-? fail to activate more effective control over HIV infection.

Dataset Information

IFN-?3 inhibits HIV infection of macrophages through the JAK-STAT pathway.

Publications

IFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure